NASDAQ:AIMD - Nasdaq - US00902F3038 - Common Stock - Currency: USD
NASDAQ:AIMD (2/20/2025, 8:00:00 PM)
0.6321
-0.03 (-4.23%)
The current stock price of AIMD is 0.6321 USD. In the past month the price decreased by -13.62%. In the past year, price decreased by -23.75%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABBV | ABBVIE INC | 19.85 | 354.98B | ||
AMGN | AMGEN INC | 15.03 | 159.99B | ||
GILD | GILEAD SCIENCES INC | 23.87 | 137.10B | ||
VRTX | VERTEX PHARMACEUTICALS INC | 1656.31 | 123.40B | ||
REGN | REGENERON PHARMACEUTICALS | 15.25 | 76.09B | ||
ARGX | ARGENX SE - ADR | N/A | 39.34B | ||
ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.37B | ||
BNTX | BIONTECH SE-ADR | N/A | 28.26B | ||
ONC | BEIGENE LTD-ADR | N/A | 26.06B | ||
NTRA | NATERA INC | N/A | 22.20B | ||
BIIB | BIOGEN INC | 8.32 | 19.98B | ||
SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.01B |
Ainos, Inc. is a diversified medtech company, which engages in the development of medical technologies for point-of-care testing and safe and novel medical treatment for a broad range of disease indications. The company is headquartered in San Diego, California and currently employs 46 full-time employees. The firm's products include VELDONA clinical-stage human therapeutics, VELDONA Pet cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform. VELDONA Pet is formulated to address a variety of health issues in dogs and cats, including skin, gum, emotion, discomfort caused by allergies, eye, and weight-related issues. Its pipeline of products, which are under development, includes VELDONA human drugs, VOC POCT-Ainos Flora, VOC platform-NISD co-development, VOC POCT-Ainos Pen, VOC POCT-CHS430 and Synthetic RNA. VELDONA human drugs are the high-priority programs include oral warts for human immunodeficiency virus seropositive patients, common cold, influenza, Sjogrens syndrome and treatment for mild COVID-19 symptoms.
AINOS INC
8880 Rio San Diego Drive, Ste. 800
San Diego CALIFORNIA US
Employees: 46
Company Website: https://www.ainos.com/
Investor Relations: http://ir.ainos.com
Phone: 18588692986
The current stock price of AIMD is 0.6321 USD. The price decreased by -4.23% in the last trading session.
The exchange symbol of AINOS INC is AIMD and it is listed on the Nasdaq exchange.
AIMD stock is listed on the Nasdaq exchange.
AINOS INC (AIMD) has a market capitalization of 8.75M USD. This makes AIMD a Nano Cap stock.
AINOS INC (AIMD) currently has 46 employees.
AINOS INC (AIMD) has a support level at 0.63 and a resistance level at 0.64. Check the full technical report for a detailed analysis of AIMD support and resistance levels.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
AIMD does not pay a dividend.
AINOS INC (AIMD) will report earnings on 2025-03-06.
AINOS INC (AIMD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.77).
The outstanding short interest for AINOS INC (AIMD) is 9.81% of its float. Check the ownership tab for more information on the AIMD short interest.
ChartMill assigns a technical rating of 5 / 10 to AIMD. When comparing the yearly performance of all stocks, AIMD turns out to be only a medium performer in the overall market: it outperformed 62.1% of all stocks.
ChartMill assigns a fundamental rating of 1 / 10 to AIMD. AIMD has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months AIMD reported a non-GAAP Earnings per Share(EPS) of -2.77. The EPS decreased by -442.44% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -51.43% | ||
ROE | -89.52% | ||
Debt/Equity | 0.51 |